Tesamorelin
Also known as Egrifta
Tesamorelin is an approved injectable that boosts your own growth hormone and is used specifically to reduce deep belly (visceral) fat.
One-dose burn-down
Half-life
30 min
Tmax
15 min
Typical dose
2 mg
GHRH analog FDA-approved to reduce visceral fat in HIV-associated lipodystrophy.
Mechanism of action
Stabilized GHRH(1-44) analog stimulating endogenous GH secretion.
Short plasma half-life but downstream GH/IGF-1 effects persist longer.
Track Tesamorelin for free
Log your doses and PeptideBuddy models Tesamorelin's half-life into a live chart so you always know how much is active — plus reminders, reconstitution and protocol planning.
Start tracking free